Last edition
News about Global Pharma
Belgium Firm Eurofins Opens Bio-Pharma Services Campus at Genome Valley
Eurofins, has opened its bio-pharma services campus comprising about one lakh sq ft of laboratory and office space on 15 acres at Genome Valley in Hyderabad.
Global Pharma | 22/09/2023 | By Manvi | 1097
Venus Remedies Extends its Oncology Portfolio in South Eastern Europe
Oncology drugs constitute the largest proportion of the Serbian pharmaceutical market (projected to reach USD 397.40m in 2023), where Venus Remedies has secured five marketing approvals, all in the oncology space.
Global Pharma | 22/09/2023 | By Manvi | 718
Alkem Laboratories Ltd Brands API Business as Alkem Activa
This strategic move underscores the company’s commitment to becoming a formidable global player in the API sector.
Global Pharma | 22/09/2023 | By Manvi | 1472
SOMAI Pharmaceuticals Receive EU-GMP Certification
SOMAÍ Pharmaceuticals announces that it has received authorisation for its facility located in Lisbon, Portugal from the Portuguese Health Authority INFRAMED.
Global Pharma | 22/09/2023 | By Manvi | 752
CordenPharma announces the inauguration of increased commercial peptide production capacity with newly-upgraded facilities at CordenPharma Colorado, the largest Solid-Phase Peptide Synthesis (SPPS) Manufacturing facility worldwide.
Global Pharma | 22/09/2023 | By Manvi | 623
Pharmanovia Acquires Global Central Nervous System (CNS) Portfolio From Sanofi
The brands span four therapy areas of ongoing unmet need associated with CNS disorders - psycholeptic, anxiolytic, anti-epileptic and anti-psychotic.
Global Pharma | 19/09/2023 | By Manvi | 910
Torrent Pharma in Talks with CVC, Bain Capital for Cipla Bid
Torrent Pharmaceuticals is in talks with private equity funds CVC Capital Partners and Bain Capital to raise up to $1.5 billion to bid for India's Cipla, according to three sources with direct knowledge of the matter.<br />
Global Pharma | 19/09/2023 | By Manvi | 588
LIC Sells Over Two per cent Stake in Sun Pharma for Rs 4,699 Cr
LIC has sold two per cent of its holding in Sun Pharma for Rs 4,699 crore via open market sale.
Global Pharma | 19/09/2023 | By Manvi | 675
Blue Star Industrial Solutions specialises in quality testing and automation offerings and the collaboration with Gebhardt further strengthens its capabilities.
Global Pharma | 19/09/2023 | By Manvi | 719
Insud Pharma Opens its Oligonucleotides Centre in Genome Valley
This is the first-of-its-kind research and production centre in India focused on Oligonucleotides research and commercial production. It also ranks among the top five globally, alongside brand companies, with a focus on the U.S., European Union and numerous global markets.
Global Pharma | 19/09/2023 | By Manvi | 1015
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy